Literature DB >> 588806

Transient changes in plasma digoxin concentration and the development of cardiotoxicity.

D J Chapple, R Hughes, B F Johnson.   

Abstract

1. Eight dogs were given two infusions of digoxin 0.1 mg/kg, one over 9 min and the other one over 90 min in a randomized sequence, allowing at least 12 days between each experiment. 2. Digoxin plasma profiles reflected the rate of digoxin infusion, the peak concentration of drug attained at the end of each infusion being considerably higher but more transient after the 9 min than after the 90 min transfusion. 3. Digoxin reduced the amount of acetylstrophanthidin required to produce electrocardiographic evidence of cardiotoxicity. This increase in cardiac sensitivity at 150 and at 360 min after the start of the digoxin infusion was independent of rate of infusion. 4. These results suggest that the development of cardiotoxicity is dependent upon the quantity of digoxin delivered into the systemic circulation regardless of the plasma concentration. 5. By inference, cardiotoxicity is related solely to the amount and not the rate of absorption from a given dose of digoxin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588806      PMCID: PMC1667866          DOI: 10.1111/j.1476-5381.1977.tb08433.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Intramuscular administration of digoxin in propylene glycol.

Authors:  A GANZ; H FUJIMORI; M PENNA; T GREINER; H GOLD
Journal:  Proc Soc Exp Biol Med       Date:  1957-06

3.  Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Authors:  W G Kramer; R P Lewis; T C Cobb; W F Forester; J A Visconti; L A Wanke; H G Boxenbaum; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

Review 4.  The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques.

Authors:  H Lüllmann; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1969-01       Impact factor: 3.765

5.  Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

Authors:  R H Reuning; R A Sams; R E Notari
Journal:  J Clin Pharmacol New Drugs       Date:  1973-04

6.  Editorial: Digoxin--the regulatory viewpoint.

Authors:  J G Harter; J P Skelly; A W Steers
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

7.  Correlation of the electrophysiologic action of digoxin with serum digoxin concentration.

Authors:  I Barr; T W Smith; M D Klein; F Hagemeijer; B Lown
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

8.  A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses.

Authors:  S W Rabkin; G Grupp
Journal:  Acta Cardiol       Date:  1975       Impact factor: 1.718

9.  Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.

Authors:  D J Sumner; A J Russell
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  The relationship between cardiotoxicity and plasma digoxin concentration in conscious dogs.

Authors:  D J Chapple; R Hughes; B F Johnson
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.